Clinical Scorecard: Rosacea and IBS show bidirectional association
At a Glance
Category
Detail
Condition
Rosacea and irritable bowel syndrome (IBS)
Key Mechanisms
Shared microbial, inflammatory, epithelial-barrier, and neuroimmune pathways were proposed, but not directly evaluated in the study.
Target Population
Adults aged 20 years or older in a Korean population-based cohort.
Care Setting
Clinical care of patients with rosacea or IBS; the study provides observational epidemiologic evidence, not treatment guidance.
Key Highlights
In a retrospective cohort, rosacea was associated with a 30% higher adjusted hazard of subsequently developing IBS.
IBS was associated with a 61% higher adjusted hazard of subsequently developing rosacea; the absolute incidence of rosacea remained low.
The associations persisted in sensitivity analyses adjusting for isotretinoin, doxycycline, and minocycline exposure, although estimates were somewhat attenuated.
Sex-based analyses found no statistically significant association between rosacea and subsequent IBS among women; associations were reported for men with rosacea and for men and women with IBS.
The observational design cannot establish causality, and administrative diagnoses lacked disease-severity and IBS-subtype information.
Guideline-Based Recommendations
Diagnosis
The study evaluated diagnoses identified through administrative codes; it did not provide diagnostic criteria or recommendations.
Management
The authors advised physicians managing either condition to be aware of the potential coexistence of the other.
The study did not assess treatment effectiveness or establish treatment-related effects.
Monitoring & Follow-up
No monitoring protocol was evaluated or recommended.
Risks
More frequent health care encounters among patients with either condition could increase the likelihood of an additional diagnosis and inflate observed associations.
The study could not establish causality; diet, stress, microbiome composition, disease severity, and IBS subtype were not assessed.
Patient & Prescribing Data
The Korean National Health Insurance Service–National Sample Cohort included 712,331 adults aged 20 years or older from 2002 to 2013. Analyses compared 1,085 patients with rosacea with 4,340 matched controls, and 244,156 patients with IBS with 244,156 matched controls.
Medication exposures including isotretinoin, doxycycline, and minocycline were assessed in sensitivity analyses. Associations were somewhat attenuated after medication adjustment; the observational analysis could not establish a treatment-related effect.
Clinical Best Practices
When managing rosacea or IBS, be aware of the potential coexistence of the other condition, as advised by the study authors.
Interpret the reported associations as observational and not as evidence that either condition causes the other.
Recognize that the proposed gut–skin mechanisms were not directly evaluated in this study.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
